approved EB-1A
Research Scholar/Postdoc
Translational Medicine · Iran · 2025-07-26
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 37 peer-reviewed articles and 2 books in high-impact journals.
Judging (Met)
The petitioner completed at least 60 journal reviews and served on editorial boards.
Original Contributions (Met)
His research in cancer immunotherapy and appendicitis diagnostics is highly cited and regarded as foundational by the scientific community.
Why This Petition Was Approved
The approval was based on the petitioner's authorship of 37 peer-reviewed journal articles, 2 preprints, and 2 books, which garnered 290 citations. His citation record placed him in the top 1% of authors in his field over the last three years. Additionally, his completion of 60 journal reviews and service on editorial boards satisfied the judging and scholarly articles criteria.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Government Alignment
Evidence Submitted
- 37 peer-reviewed journal articles
- 2 preprints
- 2 books
- 290 citations (Google Scholar)
- Top 1% of authors in translational medicine (past 3 years)
- 60 journal reviews completed
- Editorial board memberships for several leading journals
Similar Cases
Doctor
Healthcare · Taiwan
WeGreened EB-1A approved
Connecticut 14 days 2025-07-21
The petition was approved based on a substantial publication record of 33 peer-reviewed journal articles and 36 abstracts. The petitioner demonstrated global impact with 209 citations from researchers in 19 countries. Additionally, the case satisfied the judging criterion through 15 journal peer reviews and service on editorial boards.
Researcher
Healthcare · United Arab Emirates
WeGreened EB-1A rfe approved
Virginia 116 days 2025-06-09
The petitioner satisfied three EB-1A criteria: original contributions of major significance, authorship of scholarly articles, and participation as a judge of others' work. Evidence included 18 peer-reviewed publications in top journals like The Lancet and over 200 citations from 37 countries. Additionally, the petitioner completed 18 manuscript reviews and serves on an editorial board.
Research Scientist
Biotechnology · Turkey
WeGreened EB-1A approved
Utah 5 days 2025-04-02
The petition was approved based on meeting at least three EB-1A criteria, including authorship of 13 scholarly articles and 330 citations. The petitioner also demonstrated significant judging experience by reviewing 18 scholarly articles. Furthermore, the research was backed by prestigious funding from the NIH, DOD, and international foundations, proving the original and significant nature of his contributions.
Cardiologist
Healthcare · Pakistan
WeGreened EB-1A approved
Ohio 82 days 2025-03-12
The petition was approved based on 21 peer-reviewed journal publications and 21 scientific abstracts with over 120 citations. Evidence showed multiple articles ranked among the top 10% and 1% most cited in Clinical Medicine for their year of publication. The petitioner also demonstrated expert status through 13 confirmed peer reviews for high-impact medical journals.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-26.
Browse all casesAt a Glance
Outcome approved
Processing 18 days
Criteria Met 3 / 3
Evidence Types 6
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist